Multiple Myeloma: Clinical Trials

3 trials for Multiple Myeloma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 suspended. 3 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable3Suspended 3

Follow Multiple Myeloma: new trials by email Literature Review of Multiple Myeloma trials Research Report on Multiple Myeloma

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Feasibility and Effects of Exercise on Patients Suffering From Multiple Myeloma
Individual Exercise, Group Exercise - Multiple Myeloma
Not applicableSuspendedMedical University of Vienna452027-09-012026-10-09
Telemedicine-mHealth Symptom Cluster Intervention for Advanced Cancer Patients: Finding Our Center Under Stress (FOCUS)
mHealth Intervention - Lung Cancer, Breast Cancer
Not applicableSuspendedOhio State University Comprehensive Cancer Center1202026-11-152026-08-17
Efficacy and Safety Evaluation of BCMA-UCART
BCMA-UCART - Multiple Myeloma
Not applicableSuspendedBioray Laboratories202019-11-012022-05-20

Narrower conditions

Alzheimer Disease (1)  ·  Anxiety Disorders (1)  ·  Breast Neoplasms (1)  ·  Depression (1)  ·  Fatigue (1)  ·  Lung Neoplasms (1)  ·  Melanoma (1)  ·  Motor Activity (1)  ·  Neoplasms (1)  ·  Prostatic Neoplasms (1)

Broader conditions

Blood Protein Disorders (3)  ·  Cardiovascular Diseases (3)  ·  Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Hemorrhagic Disorders (3)  ·  Hemostatic Disorders (3)  ·  Immune System Diseases (3)  ·  Immunoproliferative Disorders (3)  ·  Lymphoproliferative Disorders (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms, Plasma Cell (3)  ·  Paraproteinemias (3)  ·  Vascular Diseases (3)  ·  Behavior (2)  ·  Neoplasms (2)

Sponsors

Bioray Laboratories (1)  ·  Medical University of Vienna (1)  ·  Ohio State University Comprehensive Cancer Center (1)

Countries

Austria (1)  ·  China (1)  ·  United States (1)

Top investigators

Aibin Liang, PhD (1)  ·  Richard Crevenna, Prof. MD (1)  ·  Sharla Wells-Di Gregorio, PhD (1)

NIH funding

R01CA281885 (1)